SCHEMBL13047719

SCHEMBL13047719

Cc1ccc(Cl)c(C(=O)Nc2cccc3c(=O)n(CC4CCN(C)CC4)ccc23)c1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 4/20 0.41
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
HTT P42858 1/20 0.39
POLB P06746 2/20 0.38
TP53 P04637 2/20 0.38
GAA P10253 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
HSD17B13 Q7Z5P4 1/20 0.38
MAPT P10636 2/20 0.38
GRM2 Q14416 2/20 0.38
RXFP1 Q9HBX9 1/20 0.37
CHRM3 P20309 1/20 0.37
RAB9A P51151 1/20 0.37
CNR1 P21554 2/20 0.37
CCR8 P51685 1/20 0.37
NR3C1 P04150 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13047662 0.91 TP53 (0.43) P2RX7POLBTP53MAPTGRM2
SCHEMBL13046823 0.90 CNR1 (0.41) P2RX7KDM4EALDH1A1HPGDHTT
SCHEMBL13047657 0.89 KMT2A (0.43) P2RX7ALDH1A1HPGDPOLBTP53
SCHEMBL13047724 0.88 CCR8 (0.46) P2RX7KDM4EALDH1A1HPGDHTT
SCHEMBL13047639 0.87 KDM4E (0.49) P2RX7KDM4EALDH1A1HPGDHTT
SCHEMBL13047736 0.86 CCR8 (0.46) P2RX7KDM4EALDH1A1HPGDMAPT
SCHEMBL13047706 0.86 CCR8 (0.46) P2RX7KDM4EALDH1A1HPGDMAPT
SCHEMBL13047735 0.86 WDR5 (0.43) P2RX7KDM4EALDH1A1HPGDHTT
SCHEMBL13047669 0.85 MEN1 (0.46) P2RX7ALDH1A1POLBTDP1MAPT
SCHEMBL13047642 0.84 CCR8 (0.43) P2RX7ALDH1A1HTTTP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8546579-B2 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof EVOTEC (US) INC. (US) 2013-10-01 US disclosed
US-8546579-B2 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof EVOTEC (US) INC. (US) 2013-10-01 US disclosed
US-20100292235-A1 Bicycloheteroaryl Compounds as P2x7 Modulators and Uses Thereof SECOND GENOME, INC. 2010-11-18 US disclosed
US-20100292235-A1 Bicycloheteroaryl Compounds as P2x7 Modulators and Uses Thereof SECOND GENOME, INC. 2010-11-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100292235-A1 Bicycloheteroaryl Compounds as P2x7 Modulators and Uses Thereof P2RX7, P2RX3, P2RX2 P2RX7 1/4885KDM4E 4128/4885ALDH1A1 3640/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.